학술논문

Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure.
Document Type
Article
Source
Journal of Medicinal Chemistry; 5/26/2022, Vol. 65 Issue 10, p7324-7333, 10p
Subject
Language
ISSN
00222623